ZoomRx

ZoomRx provides strategic consulting and advanced analytics to biopharma and life science companies. It leverages proprietary technology platforms—including AI-powered tools—to deliver actionable market insights that support commercial strategy, brand positioning, promotional effectiveness tracking, and decision-making across the product lifecycle. The company partners with most of the top global pharmaceutical firms.

No clinical results or pipeline as it does not develop drugs.

Key differentiators include deep industry expertise, access to over 50,000 healthcare professionals for primary research panels/surveys, robust real-world data integration capabilities, and AI-driven insight generation.

Its solutions are used by more than 100 leading pharma/biotech companies including AstraZeneca, Pfizer, Daiichi Sankyo.

Focus areas include brand strategy development in multiple therapeutic areas such as oncology and rare diseases.

Revenue estimated at $83 million in 2024 with approximately 536 employees.

Headquarters in Cambridge/Boston area with additional offices in New York City; San Francisco; Chicago; Chennai.

Founded in 2009.

Privately held.

No evidence of acquisition or IPO.